Skip to main content
Equibles
ADMA logo

ADMA · Adma Biologics, Inc. · Metrics

Track ADMA — free

Use ADMA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ADMA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.11 +0.39 (+4.01%) At close · Oct 5
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.20B
Shares
223.98M
Volume · Oct 5 3.51M Avg daily vol (3M) 2.63M

ADMA metrics

85 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$9.72
Market cap
$2.20B

Price action

20 metrics
Price change (1W)
+3.6%
Price change (30D)
+1.9%
Price change (3M)
+8.6%
Price change (6M)
+5.8%
Price change (YTD)
-46.7%
Price change (1Y)
-33.1%
Trailing year
Price change (5Y)
+716.8%
52-week high
$20.38
52-week low
$7.60
Change from 52-week high
-52.3%
Change from 52-week low
+27.9%
Annualized volatility
54.2%
Annualized volatility (3M)
40.7%
Beta
0.8
RSI (14D)
53.4
Price vs SMA 50
+3.4%
Price vs SMA 200
-17.3%
Avg volume (3M)
2.61M
Relative volume
1.1
Average dollar volume
$24.25M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
223.98M

Valuation

12 metrics
P / E (TTM)
13.9
Trailing earnings · reciprocal yield 7.2%
PEG ratio
1.0
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.3×
reciprocal yield 23.2%
P / book
5.4
reciprocal yield 18.5%
FCF yield
5.3%
TTM · current market cap
Buyback yield
8.5%
P / FCF
18.9
reciprocal yield 5.3%
P / operating cash flow
16.1
reciprocal yield 6.2%
Earnings yield
7.7%

Historical valuation

8 metrics
P / E historical average (3Y)
33.6×
reciprocal yield 3.0%
P / E historical average (5Y)
33.6×
reciprocal yield 3.0%
EV / revenue historical average (3Y)
5.9×
reciprocal yield 16.9%
EV / revenue historical average (5Y)
5.9×
reciprocal yield 16.9%
EV / EBIT historical average (3Y)
15.5×
reciprocal yield 6.4%
EV / EBIT historical average (5Y)
15.5×
reciprocal yield 6.4%
EV / EBITDA historical average (3Y)
14.9×
reciprocal yield 6.7%
EV / EBITDA historical average (5Y)
14.9×
reciprocal yield 6.7%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
8.5%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
64.7%
Operating margin
43.8%
Trailing 12 months
Net margin
33.0%
Gross profit (TTM)
$331.47M
Operating profit (TTM)
$224.48M
Net income (TTM)
$168.96M
Trailing 12 months
Diluted EPS (TTM)
$0.70
FCF margin
22.7%
Effective tax rate
22.0%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2.01

Growth

11 metrics
Revenue growth YoY
+2.0%
Year over year
Net income growth YoY
+10.5%
Revenue (TTM)
$512.27M
Trailing 12 months
EPS growth YoY
+14.3%
Shares change YoY
-7.3%
Year over year · fewer shares
Revenue CAGR (3Y)
+49.0%
Revenue CAGR (5Y)
+64.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
41.4%
Return on assets
24.7%
Debt / equity
0.5
Current ratio
7.0
EBITDA (TTM)
$232.08M
Free cash flow (TTM)
$116.47M
Quick ratio
3.8
Interest coverage
25.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$136.02M
Total assets
$684.21M
Total debt
$196.59M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$136.72M
Capital expenditures (TTM)
$20.25M
R&D (TTM)
$11.52M
SG&A (TTM)
$98.77M
Stock compensation (TTM)
$22.90M
R&D / revenue
2.2%
Stock compensation / revenue
4.5%

Ownership (13F)

3 metrics
13F filers
324
13F filer change QoQ
-35
Institutional ownership
92.5%

Short interest

3 metrics
Short interest
10.8%
Latest settlement · 10.8 days to cover
Days to cover
10.8d
Short-squeeze score
75 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1368514 CUSIP 000899104 13F (30d) 10 filings 7 filers Visit website Investor relations